Get the Stockscreener App
4.02
3.13%
-0.13
After Hours:
4.07
0.05
+1.24%
Acurx Pharmaceuticals Inc stock is traded at $4.02, with a volume of 49,484.
It is down -3.13% in the last 24 hours and down -24.26% over the past month.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.
See More
Previous Close:
$4.15
Open:
$4.07
24h Volume:
49,484
Relative Volume:
0.68
Market Cap:
$6.37M
Revenue:
-
Net Income/Loss:
$-14.58M
P/E Ratio:
-3.4957
EPS:
-1.15
Net Cash Flow:
$-9.80M
1W Performance:
-7.37%
1M Performance:
-24.26%
6M Performance:
-52.76%
1Y Performance:
-89.25%
1-Day Range:
$3.97
$4.12
1-Week Range:
$3.90
$4.81
52-Week Range:
$3.80
$44.00
Acurx Pharmaceuticals Inc Stock (ACXP) Company Profile
Name
Acurx Pharmaceuticals Inc
Sector
Industry
Phone
917-533-1469
Address
259 LIBERTY AVENUE, STATEN ISLAND
Compare ACXP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACXP
Acurx Pharmaceuticals Inc
|
4.02 | 6.58M | 0 | -14.58M | -9.80M | -1.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
381.87 | 96.56B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.58 | 60.08B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
555.51 | 61.15B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
711.09 | 44.66B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
328.71 | 36.23B | 3.81B | -644.79M | -669.77M | -6.24 |
Acurx Pharmaceuticals Inc Stock (ACXP) Latest News
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Resigns with New to The Street for Long-Form Interviews, National TV Commercials, Earned Media, and Accredited Investor Events - Shreveport Times
What machine learning models say about Acurx Pharmaceuticals Inc.Dip Buying & Verified Swing Trading Watchlist - newser.com
Acurx Pharmaceuticals Increases Authorized Common Stock Shares - TipRanks
Will breakout in Acurx Pharmaceuticals Inc. lead to full recoveryTrade Ideas & Weekly High Momentum Picks - newser.com
Acurx Pharmaceuticals Inc. stock trendline breakdownJuly 2025 Rallies & Long Hold Capital Preservation Plans - newser.com
What MACD and RSI say about Acurx Pharmaceuticals Inc.Weekly Trend Report & Technical Entry and Exit Tips - newser.com
Acurx Pharmaceuticals (NASDAQ:ACXP) Upgraded to Hold at Wall Street Zen - Defense World
Is Acurx Pharmaceuticals Inc. in accumulation or distribution phaseTrade Entry Report & Low Risk High Win Rate Stock Picks - baoquankhu1.vn
Understanding Acurx Pharmaceuticals Inc.’s price movementWall Street Watch & Free Community Supported Trade Ideas - newser.com
Acurx Pharmaceuticals Inc. stock volume spike explainedJuly 2025 Selloffs & Free Fast Gain Swing Trade Alerts - newser.com
Is Acurx Pharmaceuticals Inc stock technically oversoldShare Buyback & Weekly High Return Stock Forecasts - خودرو بانک
Bearish Setup: What is Acurx Pharmaceuticals Incs 5 year growth outlookRecession Risk & Real-Time Volume Triggers - خودرو بانک
Published on: 2025-09-20 01:31:00 - newser.com
Risk Hedge: Is Acurx Pharmaceuticals Inc a strong growth stockNew Guidance & Daily Chart Pattern Signal Reports - خودرو بانک
Acurx Pharmaceuticals shareholders approve warrant exercise and share increase - Investing.com
Using data filters to optimize entry into Acurx Pharmaceuticals Inc.2025 Fundamental Recap & Risk Controlled Stock Alerts - newser.com
Acurx Pharmaceuticals Shareholders Approve Key Issuance Plans - TipRanks
Best data tools to analyze Acurx Pharmaceuticals Inc. stockJuly 2025 Trade Ideas & Daily Technical Forecast Reports - newser.com
Using Bollinger Bands to evaluate Acurx Pharmaceuticals Inc.2025 Market WrapUp & Precise Buy Zone Identification - newser.com
Published on: 2025-09-19 13:22:33 - newser.com
Acurx Pharmaceuticals Inc. stock chart pattern explainedGap Up & Community Consensus Stock Picks - newser.com
Aug Catalysts: What is the dividend yield of Acurx Pharmaceuticals IncWeekly Investment Summary & Expert Approved Momentum Trade Ideas - خودرو بانک
What to expect from Acurx Pharmaceuticals Inc. in the next 30 daysMarket Trend Summary & Reliable Entry Point Trade Alerts - newser.com
Applying Wyckoff theory to Acurx Pharmaceuticals Inc. stockFed Meeting & Real-Time Chart Pattern Alerts - newser.com
Acurx Pharmaceuticals Inc. stock trend outlook and recovery path2025 Macro Impact & Low Drawdown Momentum Ideas - newser.com
What recovery options are there for Acurx Pharmaceuticals Inc.2025 Price Targets & Precise Trade Entry Recommendations - newser.com
How to build a dashboard for Acurx Pharmaceuticals Inc. stockQuarterly Profit Review & Risk Adjusted Buy and Sell Alerts - newser.com
Chart overlay techniques for tracking Acurx Pharmaceuticals Inc.Portfolio Gains Report & Daily Technical Stock Forecast Reports - newser.com
Risk Recap: What is Meritage Homes Corporation s 5 year growth outlookWeekly Profit Recap & Safe Capital Growth Tips - خودرو بانک
Live market analysis of Serina Therapeutics Inc.July 2025 News Drivers & Fast Entry Momentum Alerts - newser.com
Aug Rallies: What are the risks of holding Acurx Pharmaceuticals IncJuly 2025 Highlights & Detailed Earnings Play Alerts - خودرو بانک
Bull Bear: Can Acurx Pharmaceuticals Inc keep up with sector leadersWeekly Investment Summary & Technical Pattern Alert System - خودرو بانک
Treasury Yields: How do insiders feel about USB.PRQEarnings Risk Summary & Reliable Volume Spike Alerts - خودرو بانک
Bull Bear: Will Acurx Pharmaceuticals Inc. outperform the market in YEARWeekly Trend Report & Real-Time Price Movement Reports - خودرو بانک
Aug PreEarnings: What is the dividend yield of Acurx Pharmaceuticals IncQuarterly Investment Review & AI Powered Buy and Sell Recommendations - خودرو بانک
Acurx Pharmaceuticals Inc Stock (ACXP) Financials Data
Revenue
Net Income
Cash Flow
EPS
Acurx Pharmaceuticals Inc Stock (ACXP) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Sailer Carl | Director |
Jan 06 '25 |
Buy |
1.01 |
24,631 |
25,000 |
137,183 |
| LUCI DAVID P | President and CEO |
Jan 06 '25 |
Buy |
1.01 |
49,261 |
50,000 |
1,097,458 |
| Donohue James J. | Director |
Jan 06 '25 |
Buy |
1.01 |
9,852 |
10,000 |
22,352 |
| DELUCCIA ROBERT J | Director |
Jan 06 '25 |
Buy |
1.01 |
49,261 |
50,000 |
1,010,196 |
| DEAN JACK H | Director |
Jan 06 '25 |
Buy |
1.01 |
9,852 |
10,000 |
21,776 |
2.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):